Skip to main navigation Skip to search Skip to main content

470 Evaluation of cardiovascular risk factor control among people with diabetes in the community pharmacy setting a cross sectional study

Research output: Contribution to conferenceAbstractpeer-review

Abstract

Diabetes affects almost 140,000 Irish people and the prevalence is increasing.(1) In Ireland there is no structured programme in place for community pharmacists to provide care to people with diabetes, outside of dispensing medications and supplying medical devices. Research shows that community pharmacists can provide advanced services to people with diabetes that improve glycaemic control, cardiovascular risk, and medication profile.(2) A pharmacist-led intervention among people with diabetes in the Irish community pharmacy setting may be beneficial in addressing these treatment goals. However, baseline data to support this is not available.
Original languageEnglish
DOIs
Publication statusPublished - 13 Apr 2023
EventHealth Services Research and Pharmacy Practice Conference 2023 - Bradford, United Kingdom
Duration: 17 Apr 202318 Apr 2023

Conference

ConferenceHealth Services Research and Pharmacy Practice Conference 2023
Country/TerritoryUnited Kingdom
CityBradford
Period17/04/2318/04/23

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Medicine
  • Pharmacy
  • Pharmacist
  • Irish
  • Cross-sectional study
  • Data collection
  • Family medicine
  • Type 2 diabetes
  • Diabetes mellitus
  • Community pharmacy
  • Intervention (counseling)
  • Gerontology
  • Nursing
  • Philosophy
  • Linguistics
  • Statistics
  • Mathematics
  • Pathology
  • Endocrinology

Fingerprint

Dive into the research topics of '470 Evaluation of cardiovascular risk factor control among people with diabetes in the community pharmacy setting a cross sectional study'. Together they form a unique fingerprint.

Cite this